1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Executive Summary

• 2.1 Report Guide
• 2.2 Methodology
• 2.3 Market Segmentation
• 2.4 Live Cell Imaging Market- Key Findings, 2020

3. Strategic Imperatives on Global Live Cell Imaging Market

• 3.1 COVID-19 Impact Analysis
• 3.2 Market Trends- Across Types, Applications, End User Types, Countries
• 3.3 Insights into Main Market Categories
• 3.4 Market Drivers and Restraints
• 3.5 Growth Opportunities Critical for Future Success
• 3.6 Key Live Cell Imaging Companies

4. Live Cell Imaging Market Value Outlook to 2026 Outlook By Technology

• 4.1 Fluorescence recovery after photobleaching (FRAP)
• 4.2 High content screening (HCS)
• 4.3 Time lapse Microscopy
• 4.4 Fluorescence resonance energy transfer (FRET)
• 4.5 Others

5. Live Cell Imaging Market Value Outlook to 2026 Outlook By Product and Service

• 5.1 Instruments
  • 5.1.1 Standalone Systems
  • 5.1.2 Cell Analyzers
  • 5.1.3 Microscopes
  • 5.1.4 Accessories
• 5.2 Software
• 5.3 Consumables
  • 5.3.1 Assay Kits
  • 5.3.2 Reagents
  • 5.3.3 Media
  • 5.3.4 Other Consumables
• 5.4 Services

6. Live Cell Imaging Market Value Outlook to 2026 Outlook By End User

• 6.1 Academic & Research Institutes
• 6.2 Pharmaceutical & Biotechnology Companies
• 6.3 Contract Research Organizations

7. Live Cell Imaging Market Value Outlook to 2026 Outlook By Application

• 7.1 Stem Cells
• 7.2 Developmental Biology
• 7.3 Cell Biology
• 7.4 Drug Discovery

8 Asia Pacific Live Cell Imaging Market Value Outlook to 2026

• 8.1 Leading Live Cell Imaging Types contributing to Asia Pacific market
• 8.2 Top Applications contributing to Asia Pacific Live Cell Imaging
• 8.3 Top countries contributing to Asia Pacific Live Cell Imaging

9 Europe Live Cell Imaging Market Value Outlook to 2026

• 9.1 Leading Live Cell Imaging Types contributing to Europe market
• 9.2 Top Applications contributing to Europe Live Cell Imaging
• 9.3 Top countries contributing to Europe Live Cell Imaging

10 North America Live Cell Imaging Market Value Outlook to 2026

• 10.1 Leading Live Cell Imaging Types contributing to North America market
• 10.2 Top Applications contributing to North America Live Cell Imaging
• 10.3 Top countries contributing to North America Live Cell Imaging

11 South and Central America Live Cell Imaging Market Value Outlook to 2026

• 11.1 Leading Live Cell Imaging Types contributing to South and Central America market
• 11.2 Top Applications contributing to South and Central America Live Cell Imaging
• 11.3 Top countries contributing to South and Central America Live Cell Imaging

12 Middle East Africa Live Cell Imaging Market Value Outlook to 2026

• 12.1 Leading Live Cell Imaging Types contributing to Middle East Africa market
• 12.2 Top Applications contributing to Middle East Africa Live Cell Imaging
• 12.3 Top countries contributing to Middle East Africa Live Cell Imaging

13 Business Profiles of Leading Companies

• 13.1 Business Description, SWOT and Financial Analysis of Companies in Live Cell Imaging market
• 13.2 Biotek Instruments
• 13.3 Carl Zeiss AG
• 13.4 Cytosmart Technologies
• 13.5 Danaher Corporation
• 13.6 GE Healthcare
• 13.7 Nikon Corporation
• 13.8 Olympus Corporation
• 13.9 Perkinelmer
• 13.10 Sartorius AG
• 13.11 Thermo Fisher Scientific

14 Recent Industry Developments

15 Appendix

• 15.1 OGAnalysis Expertise
• 15.2 Sources and Methodology

The study predicts the short term and long term trends that can shape up the future of the Live Cell Imaging market including the COVID-19 pandemic implications for Live Cell Imagings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Live Cell Imaging market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Live Cell Imaging Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. Live Cell Imaging market forecast and Live Cell Imaging market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020- 2026 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Live Cell Imaging market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Live Cell Imaging industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Live Cell Imaging market share in developed countries.

Scope of the research-

Live Cell Imaging Market is analyzed and forecast over the outlook period from 2020 to 2026 By technology including
Fluorescence recovery after photobleaching (FRAP)
High content screening (HCS)
Time lapse Microscopy
Fluorescence resonance energy transfer (FRET)
Others

Live Cell Imaging Market is analyzed and forecast over the outlook period from 2020 to 2026 By Product including and Service
Instruments
 Standalone Systems
Cell Analyzers
Microscopes
Accessories
Software
Consumables
Assay Kits
Reagents
Media
Other Consumables
Services

Live Cell Imaging Market is analyzed and forecast over the outlook period from 2020 to 2026 By End User including
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations

Live Cell Imaging Market is analyzed and forecast over the outlook period from 2020 to 2026 By application including
Stem Cells
Developmental Biology
Cell Biology
Drug Discovery

Top Companies Operating in Live Cell Imaging market include- Biotek Instruments  , Carl Zeiss AG  , Cytosmart Technologies , Danaher Corporation  , GE Healthcare  , Nikon Corporation  , Olympus Corporation  , Perkinelmer  , 130 Sartorius AG  , 131 Thermo Fisher Scientific